KATIE WILLIAMSON: Open Payments
NPI 1114654035 · ORANGE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$353 in 16 payments from 9 companies in 2025. Trend: 2023 $583 · 2024 $288 · 2025 $353
Food & beverage: $353
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $93 |
| Gilead Sciences, Inc. | 2 | $87 |
| Axsome Therapeutics, Inc. | 2 | $41 |
| ABBVIE INC. | 2 | $33 |
| Supernus Pharmaceuticals, Inc. | 1 | $24 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $23 |
| Lilly USA, LLC | 1 | $22 |
| Kowa Pharmaceuticals America, Inc. | 1 | $17 |
| Exact Sciences Corporation | 1 | $14 |
Products named: FARXIGA, Yeztugo, Auvelity, Qelbree, Winlevi, MOUNJARO, QULIPTA, ZORYVE.
Industry payments across TX — which companies pay providers there.
